What Is “Ozempic Face”?
What Is “Ozempic Face”?
“Ozempic face” describes the hollowing and sagging some people notice after rapid weight loss on a GLP-1 medication. The change is real, and it tracks the weight loss itself. Whether these drugs do anything to facial fat beyond that is unknown, because the published evidence covers five patients.
Key takeaways
- It is a media term, not a diagnosis.
- The midface loses the most — cheeks, nasolabial folds, temples.
- The evidence is thin: one abstract, five patients.
- Never a reason to stop your medication. That is your prescriber’s conversation.
What the Term Actually Describes
When you lose a substantial amount of weight, you lose it from your face too. Facial fat sits in discrete compartments, mostly across the cheeks, temples and around the mouth, and those compartments shrink along with everything else. The skin over them does not always tighten to match.
The result reads as hollow rather than slim: flatter cheeks, deeper creases from nose to mouth, more shadow under the eyes, sometimes a looser jawline and neck. People often describe looking tired, or older, while being happy with their body.
That is the whole phenomenon. It is not a disease, it does not need treating, and giving it a brand name has made it sound more mysterious than it is.
Is It the Drug, or the Weight Loss?
This is the question almost every article on the subject gets wrong, usually by implying the medication is doing something to your face directly.
The honest answer is that the change tracks the weight loss. The identical pattern — midface hollowing, deepening nasolabial folds, neck laxity — is documented in patients who lost large amounts of weight after bariatric surgery, and that literature goes back well over a decade, long before these medications were in widespread use.
What the reviewers themselves say
The authors of the 2024 systematic review on this topic state directly that it is unknown whether GLP-1 medications affect facial fat compartments differently from bariatric surgery. They also note that drug trial reports rarely list facial fat loss as an adverse event at all. So when you read that these drugs specifically attack facial fat, that claim is not coming from the literature.
The practical upshot is reassuring: this is a known consequence of losing a lot of weight, not a strange new drug effect, and the approaches to it are the ones surgeons have been refining on post-bariatric patients for years.
How Much Evidence Is There, Really?
Less than almost anyone writing about it admits. It is worth being specific, because the gap between the confidence online and the state of the research is remarkable.
The 2024 systematic review, in numbers
- 309 records screened, leaving 14 studies in total
- 11 of the 14 were about bariatric surgery, not medication
- Only two papers discussed GLP-1 facial effects, and both were opinion pieces
- The only objective GLP-1 data came from one conference abstract covering five patients
- The authors describe “a tremendous paucity” of quantitative studies
That five-patient abstract is where the widely repeated figures come from. In those five people, average weight loss was 21.1% of body weight over 9.4 months. The superficial temporal fat pad lost 41.8% of its volume and superficial cheek fat lost 69.9%.
Those numbers are striking, and they are also five patients in a conference abstract that has not been published as a full peer-reviewed paper. The abstract was limited to a single ethnic group and measured only two facial regions. Treat the figures as a signal that something real is happening, not as a reliable estimate of what will happen to you.
You will also see a clinician quoted as saying patients on these medications looked about five years older than those not taking them. That comes from an opinion piece, and the review classifies it as such. It is a reasonable observation from someone who sees a lot of faces. It is not a study.
Which Areas Change Most
| Region | What tends to happen |
|---|---|
| Midface and mid-cheek | The largest fat loss; cheekbone area flattens |
| Nasolabial folds | Deepen as the support above them reduces |
| Temples | Hollowing; noted mainly in the GLP-1 reports |
| Under the chin and central neck | Laxity and banding become visible |
| Jawline | Jowling as skin loses its underlying volume |
| Around the mouth | Volume loss; thinning of the surrounding support |
In one series of 22 patients who went on to have facelift surgery after major weight loss, volume loss affected the midface and nasolabial folds in 88%, visible neck banding was present in 82%, and around 60% had lost volume around the mouth. Their average BMI had fallen from roughly 38 to the mid-20s.
Does It Make You Look Older?
In the small studies available, modestly — and the picture is more interesting than a simple yes.
- One cohort found mean perceived facial age rose from 40.8 to 43.7 after bariatric surgery, with patients over 40 more affected.
- Another found patients who had lost a large amount of weight appeared 5.1 years older than their actual age, against 1.2 years for those who had not.
But a third study of 14 patients found something that complicates the panic: mild weight loss made people look younger yet less attractive, while substantial weight loss made them look older yet more attractive. Perceived age and perceived attractiveness moved in opposite directions.
And a separate systematic review of four cohorts covering 129 patients reported both positive effects on facial aging and an association with facial sagging, concluding that the current evidence remains inconclusive. These are small studies that do not fully agree with one another. Anyone telling you confidently what your face will do is overreading them.
The One Claim You Will See Everywhere That Is Not Supported
“Lose weight more slowly to protect your face”
It sounds sensible. It may even turn out to be true. But the 2024 review lists the absence of any comparison between gradual and rapid weight loss as one of the specific gaps in the literature. There is no study to cite. This page is not going to assert it, and you should be slightly suspicious of pages that do — particularly if they are selling the slower method.
What Can Be Done
The useful question is not “how do I fix Ozempic face” but “is my problem lost volume, loose skin, or both?” They have different answers.
If the problem is lost volume
Volume can be restored, either with your own fat transferred from elsewhere or with injectable fillers. Worth knowing: in that series of 22 post-weight-loss facelift patients, they needed almost twice as much fat augmentation as patients who had not lost significant weight. If someone quotes you a volume based on an average patient, that may understate what you need.
If the problem is loose skin
Volume will not fix laxity, and overfilling to compensate produces a heavy, distorted result. Repositioning and tightening the tissue — a facelift, a neck lift, or work on the under-chin area specifically — is what addresses skin that no longer fits. If you want to understand what that involves, our guide to facelift technique covers what the deep plane approach is and, importantly, what it is not.
If it is both, which it usually is
Combined approaches are standard: tightening plus volume restoration in one plan. The literature on post-weight-loss patients describes exactly this combination, and in that series 91% had a facelift and all of them had fat augmentation.
Timing: Wait Until Your Weight Is Stable
This is the single most actionable thing on the page. The 2024 review describes waiting for weight stabilization — typically three to six months after bariatric surgery — before operating.
The reasoning applies just as well to medication-driven weight loss. If you are still losing, a result tailored to today’s face will not fit the face you have in six months, and you may end up paying for a revision you could have avoided by waiting. This mirrors the advice for the rest of the body, whether that is loose thigh skin or timing abdominal surgery around weight loss.
Please Do Not Stop Your Medication Over This
Said plainly
GLP-1 medications are prescribed for type 2 diabetes and for obesity. Both of those carry consequences — cardiovascular, metabolic, and otherwise — that are in a different category of seriousness from hollow cheeks.
If you do not like how your face looks, that is a reason to talk to a surgeon about your face. It is not a reason to change your treatment, and it is not a decision a plastic surgeon should be involved in. Anything to do with your medication — dose, timing, whether to continue — is a conversation with the doctor who prescribed it.
The first question is whether you are looking at lost volume, loose skin, or both — and that is a straightforward answer in person, well before anyone discusses a procedure. If your weight is still moving, a good consultation will tell you to come back, and that is a useful visit too. Dr. Michael Baumholtz is double board-certified in plastic surgery and general surgery, with more than two decades of experience in San Antonio.
Virtual consultation · Before and after gallery · Request an appointment
Frequently Asked Questions
What is Ozempic face?
It is a media term, not a medical diagnosis, for the hollowed and slightly sagging appearance some people notice in the face after substantial weight loss on a GLP-1 medication. The face loses fat along with the rest of the body, and the skin does not always tighten to match.
Is Ozempic face caused by the drug or by the weight loss?
The change tracks the weight loss. The same facial changes are well documented after bariatric surgery, years before these medications existed. Whether GLP-1 drugs do anything to facial fat beyond causing weight loss is unknown, and the authors of the 2024 systematic review say so directly.
How strong is the evidence on Ozempic face?
Weak. A 2024 systematic review found only 14 studies on facial changes after major weight loss, and 11 of them were about bariatric surgery. The only objective data specific to GLP-1 medications came from a single conference abstract covering five patients. The authors described a tremendous paucity of quantitative studies.
Which parts of the face are affected most?
The midface and mid-cheek show the largest fat loss, along with flattening of the cheekbone area and deepening of the nasolabial folds. Laxity tends to show under the chin and in the central neck, at the jawline and around the mouth. The temples and the area around the eyes were noted mainly in the GLP-1 reports.
Does major weight loss make you look older?
In the small studies available, somewhat. One cohort found mean perceived facial age rose from 40.8 before bariatric surgery to 43.7 afterward, with patients over 40 more affected. Another found patients who had lost a large amount of weight appeared 5.1 years older than their actual age, against 1.2 years for those who had not.
Should I stop my GLP-1 medication because of my face?
No, and that decision is not a plastic surgeon’s to make. These medications treat type 2 diabetes and obesity, both of which carry far more serious consequences than facial hollowing. If you are unhappy with how your face looks, that is a reason to talk to a surgeon about your face, not a reason to change your treatment. Any medication question goes to your prescriber.
Will losing weight more slowly protect my face?
Nobody knows, and this page is not going to tell you otherwise. It sounds reasonable and it is repeated everywhere, but the 2024 systematic review lists the absence of any comparison between gradual and rapid weight loss as one of the gaps in the literature. There is no study to point to.
Does Ozempic face go away on its own?
The volume does not come back unless the weight does. Lost facial fat behaves like lost fat anywhere else. Skin can retract somewhat over months, and younger skin retracts better, but established laxity in the neck and jawline generally does not resolve by itself.
What are the treatment options for facial volume loss after weight loss?
Broadly three categories, often combined: restoring volume with the patient’s own fat or with injectable fillers, repositioning and tightening tissue with a facelift or neck lift, and addressing the under-chin area directly. Which applies depends on whether your main issue is lost volume, loose skin, or both.
Do people who have lost a lot of weight need more facial filling than other patients?
In one series of 22 facelift patients, those who had lost a large amount of weight required almost twice as much fat augmentation as patients who had not. That is a single series and the figure should be read as indicative, but it matches what surgeons report.
How long should I wait before facial surgery after weight loss?
Until your weight is stable. The 2024 review describes waiting for weight stabilization, typically three to six months after bariatric surgery, before operating. Operating while weight is still falling risks a result that no longer fits your face a few months later.
Is Ozempic face only caused by Ozempic?
No. The name stuck because of one brand, but the phenomenon is about weight loss rather than any single product. Ozempic is semaglutide approved for type 2 diabetes, Wegovy is semaglutide for weight management, and tirzepatide is sold as Mounjaro and Zepbound. Substantial weight loss by any route can change the face.
The Short Answer
Facial hollowing after major weight loss is real, it is well recognized in patients who lost weight by any route, and the midface takes the biggest hit. What it is not is a mysterious drug effect, and what the research is not is settled — the objective evidence specific to these medications currently amounts to five patients in a conference abstract.
If your face bothers you, the question worth answering is whether you have lost volume, lost skin tone, or both, because the answers differ. Wait until your weight is stable before doing anything surgical. And do not let your reflection talk you out of a medication that is treating something far more consequential than your cheeks.
Sources
- Aesthetic Surgery Journal Open Forum (2024) — Soft Tissue Facial Changes Following Massive Weight Loss Secondary to Medical and Surgical Bariatric Interventions: A Systematic Review
- Obesity Surgery (2023) — Changes of Facial Features After Bariatric Surgery: a Systematic Review
This article is general information and does not replace assessment by a qualified surgeon, or advice from the clinician who prescribes your medication. Figures quoted come from small studies and, in the case of GLP-1-specific data, from a single conference abstract of five patients; they are indicative rather than predictive. Nothing here is guidance about starting, stopping, or adjusting any medication. Ozempic, Wegovy, Mounjaro and Zepbound are trademarks of their respective owners; this page is editorial and is not affiliated with or endorsed by any manufacturer. Last reviewed October 2026.
